Evidence map›Paper›PMID 32059034›Full record

ArticlePLoS pathogens2020

Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts.

Hasan Imam, Geon-Woo Kim, Saiful Anam Mir, Mohsin Khan, Aleem Siddiqui

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. pgRNA-mEpigenetics · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. ISG20 RestrictsMicroorganisms · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. [Post-transcriptional regulation mechanism and antiviral strategy of hepatitis B virus RNA].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Review
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Hasan ImamDivision of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Geon-Woo KimDivision of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.ORCID 0000-0003-0432-8268
Saiful Anam MirDivision of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.
Mohsin KhanDivision of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.ORCID 0000-0002-4142-2213
Aleem SiddiquiDivision of Infectious Diseases, Department of Medicine, University of California, San Diego, La Jolla, California, United States of America.ORCID 0000-0001-5970-7535
University of California San Diego · US

Funding

Mechanisms of HBV-Induced Innate ImmunityR01AI125350 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIDDIQUI, ALEEM · 2017 to 2021
$1.9M
Epitranscriptomic regulation of HBV gene expressionR01AI139234 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIDDIQUI, ALEEM · 2019 to 2023
$1.8M
Epitranscriptomic regulation of HBV gene expressionR56AI139234 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SIDDIQUI, ALEEM · 2018 to 2018
$393k
NIAID NIH HHS R01 AI125350NIAID NIH HHS R01 AI139234NIAID NIH HHS R56 AI139234
6 · The paper itself

Abstract

Interferon (IFN) stimulates a whole repertoire of cellular genes, collectively referred to as ISGs (Interferon-stimulated genes). ISG20, a 3´-5´ exonuclease enzyme, has been previously shown to bind and degrade hepatitis B Virus (HBV) transcripts. Here, we show that the N6-methyladenosine (m6A)-modified HBV transcripts are selectively recognized and processed for degradation by ISG20. Moreover, this effect of ISG20 is critically regulated by m6A reader protein, YTHDF2 (YTH-domain family 2). Previously, we identified a unique m6A site within HBV transcripts and confirmed that methylation at nucleotide A1907 regulates HBV lifecycle. In this report, we now show that the methylation at A1907 is a critical regulator of IFN-α mediated decay of HBV RNA. We observed that the HBV RNAs become less sensitive to ISG20 mediated degradation when methyltransferase enzymes or m6A reader protein YTHDF2 are silenced in HBV expressing cells. By using an enzymatically inactive form ISG20D94G, we further demonstrated that ISG20 forms a complex with m6A modified HBV RNA and YTHDF2 protein. Due to terminal redundancy, HBV genomic nucleotide A1907 position is acquired twice by pregenomic RNA (pgRNA) during transcription and therefore the sites of methylation are encoded within 5´ and 3´ epsilon stem loops. We generated HBV mutants that lack m6A site at either one (5´ or 3´) or both the termini (5´& 3´). Using these mutants, we demonstrated that m6A modified HBV RNAs are subjected to ISG20-mediated decay and propose sequence of events, in which ISG20 binds with YTHDF2 and recognizes m6A-modified HBV transcripts to carry out the ribonuclease activity. This is the first study, which identifies a hitherto unknown role of m6A modification of RNA in IFN-α induced viral RNA degradation and proposes a new role of YTHDF2 protein as a cofactor required for IFN-α mediated viral RNA degradation.

Indexed as

AdenosineAntiviral AgentsExonucleasesExoribonucleasesHepatitis B virusHep G2 CellsHumansInterferon-alphaInterferonsMethyltransferasesRNA-Binding ProteinsRNA StabilityRNA, ViralVirus ReplicationAdenosineAntiviral AgentsExonucleasesExoribonucleasesInterferon-alphaInterferonsISG20 protein, humanMethyltransferasesN-methyladenosineRNA-Binding ProteinsRNA, ViralYTHDF2 protein, human

Identifiers

PMID32059034
PMCPMC7046284
OpenAlexW3006455542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.